These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 15158070)

  • 1. Detection and quantitation of HBV DNA in the WHO International Standard for HIV-1 RNA (NIBSC code: 97/656).
    Shyamala V; Cottrell J; Arcangel P; Madriaga D; Linnen J; Phelps B; Chien D
    J Virol Methods; 2004 Jun; 118(1):69-72. PubMed ID: 15158070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analytical and clinical sensitivity of the Procleix Ultrio HIV-1/HCV/HBV assay in samples with a low viral load.
    Katsoulidou A; Moschidis Z; Sypsa V; Chini M; Papatheodoridis GV; Tassopoulos NC; Mimidis K; Karafoulidou A; Hatzakis A
    Vox Sang; 2007 Jan; 92(1):8-14. PubMed ID: 17181585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Standardization: a progress report.
    Saldanha J
    Biologicals; 1999 Dec; 27(4):285-9. PubMed ID: 10686054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of low HBV-DNA levels by nucleic acid amplification test (NAT) in blood donors.
    Dettori S; Candido A; Kondili LA; Chionne P; Taffon S; Genovese D; Iudicone P; Miceli M; Rapicetta M
    J Infect; 2009 Aug; 59(2):128-33. PubMed ID: 19586663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of a new molecular assay for detection of human immunodeficiency virus type 1 RNA, hepatitis C virus RNA, and hepatitis B virus DNA.
    McCormick MK; Dockter J; Linnen JM; Kolk D; Wu Y; Giachetti C
    J Clin Virol; 2006 Jul; 36(3):166-76. PubMed ID: 16427802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multicenter performance evaluation of a transcription-mediated amplification assay for screening of human immunodeficiency virus-1 RNA, hepatitis C virus RNA, and hepatitis B virus DNA in blood donations.
    Koppelman MH; Assal A; Chudy M; Torres P; de Villaescusa RG; Reesink HW; Lelie PN; Cuypers HT
    Transfusion; 2005 Aug; 45(8):1258-66. PubMed ID: 16078910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Collaborative study for the calibration of HCV RNA, HBV DNA and HIV RNA reference preparations against the relative international standards.
    Pisani G; Marino F; Cristiano K; Bisso GM; Mele C; Luciani F; Wirz M; Gentili G;
    Ann Ist Super Sanita; 2007; 43(1):69-76. PubMed ID: 17536156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of viral nucleic acid testing on contamination frequency of manufacturing plasma pools.
    Nübling CM; Unkelbach U; Chudy M; Seitz R
    Transfusion; 2008 May; 48(5):822-6. PubMed ID: 18208414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of a multiplex human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus nucleic acid testing assay to detect viremic blood donors in northern Thailand.
    Nantachit N; Thaikruea L; Thongsawat S; Leetrakool N; Fongsatikul L; Sompan P; Fong YL; Nichols D; Ziermann R; Ness P; Nelson KE
    Transfusion; 2007 Oct; 47(10):1803-8. PubMed ID: 17880604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of COBAS AmpliPrep nucleic acid extraction in conjunction with COBAS AmpliScreen HBV DNA, HCV RNA and HIV-1 RNA amplification and detection.
    Koppelman MH; Sjerps MC; Reesink HW; Cuypers HT
    Vox Sang; 2005 Nov; 89(4):193-200. PubMed ID: 16262751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative evaluation of a triplex nucleic acid test for detection of HBV DNA, HCV RNA, and HIV-1 RNA, with the Procleix Tigris System.
    Xiao X; Zhai J; Zeng J; Tian C; Wu H; Yu Y
    J Virol Methods; 2013 Feb; 187(2):357-61. PubMed ID: 23142222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of two automated nucleic acid testing systems for simultaneous detection of human immunodeficiency virus and hepatitis C virus RNA and hepatitis B virus DNA.
    Margaritis AR; Brown SM; Seed CR; Kiely P; D'Agostino B; Keller AJ
    Transfusion; 2007 Oct; 47(10):1783-93. PubMed ID: 17880602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiplex real-time quantitative RT-PCR assay for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus type 1.
    Candotti D; Temple J; Owusu-Ofori S; Allain JP
    J Virol Methods; 2004 Jun; 118(1):39-47. PubMed ID: 15158067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Head-to-head comparison of two transcription-mediated amplification assay versions for detection of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus Type 1 in blood donors.
    Grabarczyk P; van Drimmelen H; Kopacz A; Gdowska J; Liszewski G; Piotrowski D; Górska J; Kuśmierczyk J; Candotti D; Lętowska M; Lelie N; Brojer E
    Transfusion; 2013 Oct; 53(10 Pt 2):2512-24. PubMed ID: 23590145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the analytical and operational performance of two viral nucleic acid test blood screening systems: Procleix Tigris and cobas s 201.
    Assal A; Barlet V; Deschaseaux M; Dupont I; Gallian P; Guitton C; Morel P; David B; De Micco P
    Transfusion; 2009 Feb; 49(2):289-300. PubMed ID: 19000230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An international collaborative study to establish the 2nd World Health Organization International Standard for hepatitis B virus DNA nucleic acid amplification technology-based assays.
    Baylis SA; Heath AB; Chudy M; Pisani G; Klotz A; Kerby S; Gerlich W
    Vox Sang; 2008 May; 94(4):358-62. PubMed ID: 18266781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accuracy to 2nd International HIV-1 RNA WHO Standard: assessment of three generations of quantitative HIV-1 RNA nucleic acid amplification tests.
    Glaubitz J; Sizmann D; Simon CO; Hoffmann KS; Drogan D; Hesse M; Lang G; Kroeh M; Simmler P; Dewald M; Haberhausen G; Lindauer A; Beyser K; Reber A; Baumeister A; Wolf E; Jaeger H; Babiel R
    J Clin Virol; 2011 Feb; 50(2):119-24. PubMed ID: 21109484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Status of NAT screening for HCV, HIV and HBV: experience in Japan.
    Tomono T; Murokawa H; Minegishi K; Yamanaka R; Lizuka HY; Miyamoto M; Satoh S; Nakahira S; Murozuka T; Emura H; Doi Y; Mine H; Yokoyama S; Ohnuma H; Tanaka T; Yoshikawa A; Nishioka K;
    Dev Biol (Basel); 2002; 108():29-39. PubMed ID: 12220140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. World Health Organization collaborative study to calibrate the 3rd International Standard for Hepatitis C virus RNA nucleic acid amplification technology (NAT)-based assays.
    Baylis SA; Heath AB;
    Vox Sang; 2011 May; 100(4):409-17. PubMed ID: 21488880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. External quality assessment for the detection of HCV RNA, HIV RNA and HBV DNA in plasma by nucleic acid amplification technology: a novel approach.
    Pisani G; Marino F; Cristiano K; Bisso GM; Mele C; Luciani F; Wirz M; Gentili G;
    Vox Sang; 2008 Jul; 95(1):8-12. PubMed ID: 18380770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.